Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Differentially expressed downstream genes in cells with normal or mutated p53.

Hao Xu1, M Raafat El-Gewely

  • 1Department of Biotechnology, Institute of Medical Biology, University of Tromsø, 9037 Tromsø, Norway.

Oncology Research
|May 3, 2003
PubMed
Summary

Mutations in the p53 tumor suppressor gene can drive cancer. This study reveals distinct gene expression profiles for various p53 mutants, uncovering new insights into their oncogenic functions and alternative splicing.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Inhibition of Wnt/β-catenin signal is alleviated reactive gliosis in rats with hydrocephalus.

Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery·2015
Same author

Copper-catalyzed one-pot synthesis of 1,2,4-triazoles from nitriles and hydroxylamine.

The Journal of organic chemistry·2015
Same author

Applications of data mining methods in the integrative medical studies of coronary heart disease: progress and prospect.

Evidence-based complementary and alternative medicine : eCAM·2014
Same author

Remediation of pharmaceuticals and personal care products using an aerobic granular sludge sequencing bioreactor and microbial community profiling using Solexa sequencing technology analysis.

Bioresource technology·2014
Same author

Anti-Inflammatory and Immunomodulatory Mechanism of Tanshinone IIA for Atherosclerosis.

Evidence-based complementary and alternative medicine : eCAM·2014
Same author

Anti-inflammatory immune skewing is atheroprotective: Apoe−/−FcγRIIb−/− mice develop fibrous carotid plaques.

Journal of the American Heart Association·2014

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Mutations in the p53 tumor suppressor gene are common in human cancers.
  • These mutations can result in loss of function, negative complementation, or gain-of-oncogenic functions, increasing tumor growth and spread.

Purpose of the Study:

  • To investigate the distinct gene expression profiles of specific cancer-related p53 mutants (A138T, C141Y, R158L, G245C, R248Q).
  • To understand the role of p53 in cancer by analyzing its network gene expression.
  • To identify genes uniquely responsive to p53 mutants, indicating gain-of-function effects.

Main Methods:

  • Utilized a modified differential display technique.
  • Established response profiles for plasmid-expressed wild-type p53, p53 mutants, and p53-null cells.

Related Experiment Videos

  • Analyzed gene expression patterns to differentiate between cellular states.

    • Main Results:

    • Demonstrated significant differences in gene expression patterns between p53-null, wild-type p53, and various p53 mutant samples.
    • Identified unique expression profiles associated with specific p53 mutants.
    • Reported the first instance of p53 mutant-triggered alternative splicing.

    Conclusions:

    • The distinct gene expression profiles of p53 mutants provide insights into their oncogenic potential.
    • Understanding these profiles aids in accurate cancer diagnosis, treatment, and prognosis.
    • The discovery of p53 mutant-triggered alternative splicing opens new avenues for cancer research.